Table 5.
Triglyceride (natural log-transformed) and risk for CVD mortality among 26 413a adults, stratified by diabetes and pre-existing CVDb
| Groups | n | HRc | 95% CI | P-value |
|---|---|---|---|---|
| Participants without diabetes | ||||
| ȃWithout pre-existing CVD | 21 283 | 0.88 | 0.76–1.02 | 0.088 |
| ȃWith pre-existing CVD | 1179 | 1.01 | 0.77–1.31 | 0.967 |
| Participants with diabetes | ||||
| ȃWithout pre-existing CVD | 3309 | 1.29 | 1.02–1.63 | 0.032 |
| ȃWith pre-existing CVD | 642 | 1.54 | 1.09–2.18 | 0.015 |
CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio.
A total of 157 participants were excluded due to unknown status of pre-existing CVD. Therefore, the remaining 26 413 participants were included in the analysis.
Pre-existing CVD was defined as prior diagnosis of myocardial infarction or stroke.
Adjusted for age, sex, ethnicity, obesity, poverty–income ratio, education, physical activity, alcohol consumption, smoking status, survey period, hypercholesterolaemia, hypertension, family history of diabetes, duration of diabetes, and diabetes medications.